Bioavailability, Pharmacokinetics and Safety of ESR 1150 CL in Healthy Adult Male Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To investigate the bioavailability of ESR 1150 CL by the time course determination of plasma
concentration (pharmacokinetics) of no-transformed ESR 1150 after single administration to
healthy adult male volunteers. Secondary objective is to investigate the safety of ESR 1150
CL.